SCHEMBL4250087

SCHEMBL4250087

CCCCCCCCCCCC[N+](C)(C)CC#N.COS(=O)(=O)[O-]

nearest known ligand 0.45

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 6/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
RAB9A P51151 4/20 0.45
LMNA P02545 4/20 0.45
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45
GAA P10253 1/20 0.45
MAPT P10636 1/20 0.45
NPC1 O15118 1/20 0.44
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
DNM1 Q05193 7/20 0.41
HSP90AA1 P07900 2/20 0.39
RAD52 P43351 2/20 0.39
RECQL P46063 2/20 0.39
GLA P06280 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
EPHX2 P34913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5078709 0.89 RECQL (0.40) HTTSMN1; SMN2RAB9ALMNAKMT2A
SCHEMBL4660265 0.87 RECQL (0.58) HTTSMN1; SMN2RAB9ALMNAKMT2A
SCHEMBL10420709 0.85 HTT (0.60) HTTLMNAKMT2ADNM1HSP90AA1
SCHEMBL5880997 0.85 HTT (0.60) HTTLMNAKMT2ADNM1HSP90AA1
Didecyldimethylammonium SCHEMBL3936454 0.85 HTT (0.60) HTTLMNAKMT2ADNM1HSP90AA1
SCHEMBL1547985 0.85 HTT (0.60) HTTLMNAKMT2ADNM1HSP90AA1
SCHEMBL7767862 0.85 HTT (0.60) HTTLMNAKMT2ADNM1HSP90AA1
SCHEMBL10806075 0.85 HTT (0.60) HTTLMNAKMT2ADNM1HSP90AA1
SCHEMBL5803866 0.85 HTT (0.60) HTTLMNAKMT2ADNM1HSP90AA1
SCHEMBL27542884 0.85 HTT (0.60) HTTLMNAKMT2ADNM1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149668-A1 Method for Producing Sodium Chloride-Free Ammonium Nitriles CLARIANT INTERNATIONAL, LTD. (CH) 2009-06-11 US disclosed
EP-2001836-A1 IMPROVED METHOD FOR PRODUCING SODIUM CHLORIDE-FREE AMMONIUM NITRILES CLARIANT INTERNATIONAL LTD. (CH) 2008-12-17 EP disclosed
WO-2007110163-A1 IMPROVED METHOD FOR PRODUCING SODIUM CHLORIDE-FREE AMMONIUM NITRILES CLARIANT INTERNATIONAL LTD (CH) 2007-10-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149668-A1 Method for Producing Sodium Chloride-Free Ammonium Nitriles CBR3, CBR1, AKR1C3 HTT 2436/4885SMN1; SMN2 3631/4885RAB9A 4251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.